A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
Patients will be assigned to one of three treatment groups. Study medication is administered over a 52 week study duration.
Epistemonikos ID: 293aa12cbc93d47d4ed490f6c9d2150e6dfb1c95
First added on: Nov 02, 2017